Vanguard Group Inc Immunity Bio, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 21,817,307 shares of IBRX stock, worth $53.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,817,307
Previous 20,344,554
7.24%
Holding current value
$53.9 Million
Previous $61.2 Million
5.94%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding IBRX
# of Institutions
275Shares Held
120MCall Options Held
2.5MPut Options Held
3.14M-
Black Rock Inc. New York, NY11.4MShares$28.2 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC8.76MShares$21.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY7.76MShares$19.2 Million0.36% of portfolio
-
Jane Street Group, LLC New York, NY7.72MShares$19.1 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$18.8 Million0.0% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $989M
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...